Latest filing published 10 Sept 2024 for Longevity Health Holdings, Inc., €463.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -84.1%Entry US$14.55 · Close at T+365 US$2.32
- -82.8%Entry US$15.00 · Close at T+365 US$2.58
- -94.1%Entry US$117.00 · Close at T+365 US$6.90
- -92.1%Entry US$105.90 · Close at T+365 US$8.34
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Gilles Spenlehauer: trading record in brief
Gilles Spenlehauer discloses dealings in Longevity Health Holdings, Inc. to SEC (Form 4). In total, 14 filings cover trades dated from 4 December 2023 to 6 September 2024.
No open-market sale appears; the market trades are 14 purchases worth €20k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2024 alone, the filings show 4 purchases and no sales.
Half of the purchases are above €915 and half below. Of 8 purchases, 8 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 5 purchases show a median change of -37.2%, with the price up in 0% of them. This is a record of the past, not a forecast.
Most recently, on 10 September 2024, the filings show an open-market purchase worth €463 in Longevity Health Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gilles Spenlehauer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,009 shares@ US$0.516.5% of flowCommon StockSEC:0000950170-24-105170:0Canonical exit: 5 Dec 2024 (T+90)
- 87 shares@ US$0.570.6% of flowCommon StockSEC:0000950170-24-103448:0Canonical exit: 28 Nov 2024 (T+90)
- 522 shares@ US$0.566.3% of flowCommon StockSEC:0000950170-24-102372:1Canonical exit: 27 Nov 2024 (T+90)
- 599 shares@ US$0.564.3% of flowCommon StockSEC:0000950170-24-102372:0Canonical exit: 26 Nov 2024 (T+90)
- 591 shares@ US$3.94Common StockSEC:0000950170-23-071167:1Canonical exit: 14 Mar 2024 (T+90)
- 313 shares@ US$3.611914.6% of flowCommon StockSEC:0000950170-23-071167:0Canonical exit: 13 Mar 2024 (T+90)
- 869 shares@ US$3.50Common StockSEC:0000950170-23-070167:1Canonical exit: 11 Mar 2024 (T+90)
- 869 shares@ US$5.57Common StockSEC:0000950170-23-070167:2Canonical exit: 12 Mar 2024 (T+90)
- 870 shares@ US$3.527140.2% of flowCommon StockSEC:0000950170-23-070167:0Canonical exit: 10 Mar 2024 (T+90)
- 36 shares@ US$3.150.1% of flowCommon StockSEC:0000950170-23-069156:4Canonical exit: 7 Mar 2024 (T+90)
- 277 shares@ US$3.10Common StockSEC:0000950170-23-069156:1Canonical exit: 4 Mar 2024 (T+90)
- 487 shares@ US$3.03Common StockSEC:0000950170-23-069156:2Canonical exit: 5 Mar 2024 (T+90)
- 199 shares@ US$3.07Common StockSEC:0000950170-23-069156:3Canonical exit: 6 Mar 2024 (T+90)
- 870 shares@ US$2.998433.8% of flowCommon StockSEC:0000950170-23-069156:0Canonical exit: 3 Mar 2024 (T+90)
14 of 11 declarations